Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma

┬╖
┬╖ Springer Nature
рдЗ-рдкреБрд╕реНрддрдХ
422
рдкреГрд╖реНрдард╣рд░реВ
рд░реЗрдЯрд┐рдЩ рд░ рд░рд┐рднреНрдпреВрд╣рд░реВрдХреЛ рдкреБрд╖реНрдЯрд┐ рдЧрд░рд┐рдПрдХреЛ рд╣реБрдБрджреИрди ┬ардердк рдЬрд╛рдиреНрдиреБрд╣реЛрд╕реН

рдпреЛ рдЗ-рдкреБрд╕реНрддрдХрдХрд╛ рдмрд╛рд░реЗрдорд╛

The field of kidney cancer has dramatically evolved over the past several years due to notable advances. Most importantly, systemic treatment options have expanded to include combination regimens for advanced disease and expansion of treatment options in the adjuvant setting. Additionally, surgical management has evolved towards nephron-sparing and minimally invasive approaches for treatment of localized disease; the role of surgery and focal therapy are changing for patients with advanced disease. While kidney cancer is a common malignancy in both men and women worldwide, mortality has improved over time given advancements in modern oncology.
This book provides a comprehensive, state-of-the art review of the field, and serves as a valuable resource for clinicians, surgeons and researchers with an interest in kidney cancer. The book reviews new data about systemic treatment options for patients with advanced disease including strategies in the treatment na├пve and post frontline setting. It covers new data regarding perioperative and adjuvant treatments for patients with localized disease and will highlight novel targets and treatments under development. Integration of surgery and systemic therapy through cytoreductive and consolidative approaches has yielded provocative data that promises to further advance the field, and major advances in this domain will also be discussed. Additionally, the book discusses the evolving role of alternative focal approaches including radiation therapy for patients with advanced disease.
This text serves as a very useful resource for physicians and researchers dealing with and interested in this challenging malignancy. Specifically, urologists, medical oncologists, radiation oncologists, basic science and translational researchers with interest in RCC, fellows in urologic oncology, upper level residents training in urology and medical oncology, and pharmaceutical partners interested in RCCwill benefit most significantly. Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma will provide a concise yet comprehensive summary of strategies for sequencing therapies that will help guide patient care and stimulate investigative efforts.

рд▓реЗрдЦрдХрдХреЛ рдмрд╛рд░реЗрдорд╛

Rana R. McKay, MDAssociate Professor of Medicine and UrologyAssociate Director, Translational SciencesCo-Lead, Genitourinary Oncology Program Moores Cancer Center University of California San Diego3855 Health Sciences Drive La Jolla, CA 92037USA
Eric A. Singer, MD, MA, MS, FACS, FASCO
The Dave Longaberger Endowed Chair in Urology
Professor of Urology and Bioethics
Chief, Division of Urologic Oncology
Director, Urologic Oncology Fellowship
The Ohio State University Comprehensive Cancer Center
915 Olentangy River Road, Suite 3100, Columbus, OH, 43212
USA

рдпреЛ рдЗ-рдкреБрд╕реНрддрдХрдХреЛ рдореВрд▓реНрдпрд╛рдЩреНрдХрди рдЧрд░реНрдиреБрд╣реЛрд╕реН

рд╣рд╛рдореАрд▓рд╛рдИ рдЖрдлреНрдиреЛ рдзрд╛рд░рдгрд╛ рдмрддрд╛рдЙрдиреБрд╣реЛрд╕реНред

рдЬрд╛рдирдХрд╛рд░реА рдкрдвреНрджреИ

рд╕реНрдорд╛рд░реНрдЯрдлреЛрди рддрдерд╛ рдЯреНрдпрд╛рдмрд▓реЗрдЯрд╣рд░реВ
Android рд░ iPad/iPhone рдХрд╛ рд▓рд╛рдЧрд┐┬аGoogle Play рдХрд┐рддрд╛рдм рдПрдк рдХреЛ рдЗрдиреНрд╕реНрдЯрд▓ рдЧрд░реНрдиреБрд╣реЛрд╕реНред рдпреЛ рддрдкрд╛рдИрдВрдХреЛ рдЦрд╛рддрд╛рд╕реЕрдВрдЧ рд╕реНрд╡рддрдГ рд╕рд┐рдВрдХ рд╣реБрдиреНрдЫ рд░ рддрдкрд╛рдИрдВ рдЕрдирд▓рд╛рдЗрди рд╡рд╛ рдЕрдлрд▓рд╛рдЗрди рдЬрд╣рд╛рдБ рднрдП рдкрдирд┐┬ардЕрдзреНрдпрдпрди рдЧрд░реНрди рджрд┐рдиреНрдЫред
рд▓реНрдпрд╛рдкрдЯрдк рддрдерд╛ рдХрдореНрдкреНрдпреБрдЯрд░рд╣рд░реВ
рддрдкрд╛рдИрдВ Google Play рдорд╛ рдЦрд░рд┐рдж рдЧрд░рд┐рдПрдХреЛ рдЕрдбрд┐рдпреЛрдмреБрдХ рдЖрдлреНрдиреЛ рдХрдореНрдкреНрдпреБрдЯрд░рдХреЛ рд╡реЗрдм рдмреНрд░рд╛рдЙрдЬрд░ рдкреНрд░рдпреЛрдЧ рдЧрд░реЗрд░ рд╕реБрдиреНрди рд╕рдХреНрдиреБрд╣реБрдиреНрдЫред
eReaders рд░ рдЕрдиреНрдп рдЙрдкрдХрд░рдгрд╣рд░реВ
Kobo eReaders рдЬрд╕реНрддрд╛ e-ink рдбрд┐рднрд╛рдЗрд╕рд╣рд░реВрдорд╛ рдлрд╛рдЗрд▓ рдкрдвреНрди рддрдкрд╛рдИрдВрд▓реЗ рдлрд╛рдЗрд▓ рдбрд╛рдЙрдирд▓реЛрдб рдЧрд░реЗрд░ рдЙрдХреНрдд рдлрд╛рдЗрд▓ рдЖрдлреНрдиреЛ рдбрд┐рднрд╛рдЗрд╕рдорд╛ рдЯреНрд░рд╛рдиреНрд╕реНрдлрд░ рдЧрд░реНрдиреБ рдкрд░реНрдиреЗ рд╣реБрдиреНрдЫред рддреА рдлрд╛рдЗрд▓рд╣рд░реВ рдкрдвреНрди рдорд┐рд▓реНрдиреЗ рдЗрдмреБрдХ рд░рд┐рдбрд░рд╣рд░реВрдорд╛ рддреА рдлрд╛рдЗрд▓рд╣рд░реВ рдЯреНрд░рд╛рдиреНрд╕реНрдлрд░ рдЧрд░реНрдиреЗрд╕рдореНрдмрдиреНрдзреА рд╡рд┐рд╕реНрддреГрдд рдирд┐рд░реНрджреЗрд╢рдирд╣рд░реВ рдкреНрд░рд╛рдкреНрдд рдЧрд░реНрди рдорджреНрджрдд рдХреЗрдиреНрджреНрд░ рдорд╛ рдЬрд╛рдиреБрд╣реЛрд╕реНред